Tag: Ild

According to Health Affairs, current definitions for specialty drugs lack consistency, but many share common traits, such as high cost, complex administration, and specialized handling. For patients and providers, the classification of **OFEV a specialty drug** is critical, as it dictates everything from dispensing procedures to insurance coverage and support programs. This designation reflects the medication's high cost and complex nature, requiring a specific distribution model and extensive patient support.

While many life-saving medications exist, drug-induced interstitial lung disease (DIILD) is a recognized but potentially overlooked side effect, accounting for 3% to 5% of all ILD cases. Understanding **which drugs cause ILD** is a critical first step for patients and clinicians to ensure early detection and management of this serious condition.